# A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

> **NCT02782481** · PHASE3 · WITHDRAWN · sponsor: **NeuroDerm Ltd.**

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** ND0612
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02782481
- **Lead sponsor:** NeuroDerm Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08
- **Primary completion:** 2018-10-15
- **Final completion:** 2018-10-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Decision to change the study design
- **Last updated:** 2019-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02782481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02782481, "A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT02782481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*